Jérôme Galon

25PUBLICATIONS
211CO-AUTHORS
Predictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Formal methods for softwareMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Jun 10, 2026
Immune microenvironment and noncoding RNA shape early colorectal carcinogenesis in patients with premalignant lesions.

|Jan 04, 2026
A live tumor fragment platform to assess immunotherapy response in core needle biopsies while addressing challenges of tumor heterogeneity.

T S Ramasubramanian, Pichet Adstamongkonkul, Christina M Scribano

|Aug 12, 2025
A live tumor fragment platform to assess immunotherapy response in core needle biopsies while addressing challenges of tumor heterogeneity.

T S Ramasubramanian, Pichet Adstamongkonkul, Christina M Scribano

|Jul 07, 2025
Facts and Hopes: CAR T-Cell Therapy and Immune Contexture in Non-Hodgkin Lymphoma.

Assia Hijazi, Frederick L Locke, Nathalie Scholler

|Feb 04, 2025
Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials.

Julien Taieb, John Souglakos, Ioannis Boukovinas

|Jun 12, 2024
Upfront Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan Plus Bevacizumab With or Without Atezolizumab for Patients With Metastatic Colorectal Cancer: Updated and Overall Survival Results of the ATEZOTRIBE Study.

Carlotta Antoniotti, Daniele Rossini, Filippo Pietrantonio

Pageof 5

Frequent Collaborators

4 joint publications

Franck Pagès

3 joint publications

Davide Bedognetti

3 joint publications

Aurelie Catteau

2 joint publications

Frederick L Locke